Posts by Keming Yang, MD, PhD
-
Mortality Risk Significantly Greater With Interval CRC Than Screen-detected CRC
Keming Yang, MD, PhD, Andrew T. Chan, MD, MPH, and colleagues detected significantly increased mortality for individuals with interval colorectal cancer (CRC) than for those with screen-detected CRC, and differences in established clinical prognostic factors, genetic characteristics, could not explain the discrepancy.
Biography
Keming Yang, MD, PhD, is a postdoc research fellow in the Clinical and Translational Epidemiology Unit of the Department of Medicine at Massachusetts General Hospital.